CRISPR Controversy Continues Despite Patent Win for Zhang – Medscape
Medscape |
CRISPR Controversy Continues Despite Patent Win for Zhang
Medscape LA JOLLA, California — In his first public presentation since he was awarded a contested patent for CRISPR gene-editing technology, Feng Zhang, PhD, from the Broad Institute of MIT and Harvard University in Cambridge, did not address the controversial … USA |
